Medicinal and other products and human and animal transmissible spongiform encephalopathies: Memorandum from a WHO meeting

Aguzzi, A.; Barbara, J.; Brown, P.; Budka, H.; Diringer, H.; Dormont, D.; Flanagan, P.; Heeschen, W.; Hope, J.; Hornlimann, B.; Kenney, K.; Masters, C.; Macnaughton, M. R.; Pocchiari, M.; Rohwer, R. G.; Safar, J.; Somogyi, A.; Tateishi, J.; Taylor, D.; Van Duijn, C. M.; Wilesmith, J. W.; Will, R.; Wisher, M.; Asher, D.; De Pedro, J.; Feek, C.; Hasebe, K.; Horaud, F.; Lower, J.; Minor, P.; Nandapalan, P.; Pavlov, A.; Perez, A. C.; Ricketts, M.; Vicari, G.; Van Aken, W. G.; Beal, R.; Menache-Aronson, D.; Bradley, R.; Bailey, A.; Chalumeau, H. P.; Van Aken, W. G.; Garland, A.; Brooks, W.; Schrieber, R.; Sprengers, E.; Andjaparidze, A. G.; Bolis, C. L.; Emmanuel, J. C.; Griffiths, E.; Heymann, D. L.; Kaboyo, W.; Meslin, F. X.; Miyagawa, S.; Marroquin, A. P.; Schudel, A.; Zeidler, M.

Medicinal and other products and human and animal transmissible spongiform encephalopathies: Memorandum from a WHO meeting

Tools

Aguzzi, A., Barbara, J., Brown, P., Budka, H., Diringer, H., Dormont, D., Flanagan, P., Heeschen, W., Hope, J., Hornlimann, B., Kenney, K., Masters, C., Macnaughton, M. R., Pocchiari, M., Rohwer, R. G., Safar, J., Somogyi, A., Tateishi, J., Taylor, D., Van Duijn, C. M., Wilesmith, J. W., Will, R., Wisher, M., Asher, D., De Pedro, J., Feek, C., Hasebe, K., Horaud, F., Lower, J., Minor, P., Nandapalan, P., Pavlov, A., Perez, A. C., Ricketts, M., Vicari, G., Van Aken, W. G., Beal, R., Menache-Aronson, D., Bradley, R., Bailey, A., Chalumeau, H. P., Van Aken, W. G., Garland, A., Brooks, W., Schrieber, R., Sprengers, E., Andjaparidze, A. G., Bolis, C. L., Emmanuel, J. C., Griffiths, E., Heymann, D. L., Kaboyo, W., Meslin, F. X., Miyagawa, S., Marroquin, A. P., Schudel, A. and Zeidler, M. (1997) Medicinal and other products and human and animal transmissible spongiform encephalopathies: Memorandum from a WHO meeting. Bulletin of the World Health Organization, 75 (6). pp. 505-513. ISSN 0042-9686

Full text not available from this repository. (Request a copy)

Abstract

The report in March 1996 of 10 human cases of a novel form of Creutzfeldt-Jakob disease in the United Kingdom, and its possible link to the agent that causes bovine spongiform encephalopathy (BSE), raises many questions about the safety of animal-derived products and by-products entering the food chain or being used in medicine. This Memorandum updates the preventive measures put forward in 1991 to minimize the risks associated with the use of bovine-derived materials in medicinal products and medical devices.

Item Type:	Article
Uncontrolled Keywords:	public health, environmental and occupational health,sdg 3 - good health and well-being ,/dk/atira/pure/subjectarea/asjc/2700/2739
Faculty \ School:	Faculty of Science > School of Biological Sciences
Related URLs:	http://www.scopus.com/inward/record.url?...
Depositing User:	LivePure Connector
Date Deposited:	08 Dec 2025 16:30
Last Modified:	15 Dec 2025 01:19
URI:	https://ueaeprints.uea.ac.uk/id/eprint/101325
DOI:

Actions (login required)

View Item